View of A Cost Effectiveness Analysis of Intravitreal Injections of Bevacizumab, Ranibizumab, and Aflibercept for the Treatment of Diabetic Macular Edema

Return to Article Details A Cost Effectiveness Analysis of Intravitreal Injections of Bevacizumab, Ranibizumab, and Aflibercept for the Treatment of Diabetic Macular Edema Download Download PDF